Prefer to view this content on our website? Click here.
Dear Fellow Investor,
Company: Moderna (SYM: MRNA)
Keep an eye on Moderna (SYM: MRNA).
After surging during the pandemic, the stock now trades at less than $43 a share.
However, it’s starting to see upside thanks to a few strong catalysts...
Trading Tips
10 Must-Buy Stocks Under $10 for 2025
Smart investors know timing is everything. This report features 10 stocks under $10 that could offer massive upside potential in 2025.
If you're looking for value-packed picks at a low cost, this is the list you need.
(By clicking this link you agree to receive emails from Trading Tips and our affiliates. You can opt out at any time.)
For one, Oracle Chairman Larry Ellison praised the potential of artificial intelligence in developing cancer vaccines. In fact, as noted by Investor’s Business Daily, “Ellison claimed using AI, a messenger RNA-based vaccine could be produced robotically in just 48 hours. Moderna is using its mRNA technology to develop a cancer vaccine in partnership with Merck. Moderna is using the same platform it used to create its Covid vaccine, Spikevax.”
Two, the company just received $590 million from the US Department of Health and Human Services (HHS). The company was tasked with developing an mRNA vaccine that protects against H5 and H7 avian influenzas—also known simply as bird flu.
(More info after ad)
Brownstone Research
Your retirement is inside this building
Take a good look at the building pictured below…
Tech investing legend Jeff Brown says this building could pay for your retirement.
Brown has built his career on being ahead of the curve when it comes to technology.
He recommended Bitcoin when it was just $240…
Picked out Nvidia in 2016 at a split-adjusted 66 cents…
He called the rise of electric cars…
And artificial intelligence.
Right now, he says what's in that building could help pay for your retirement.
And three, the company has a vaccine in Phase 3 trials for a norovirus.
According to CNBC, “Norovirus is a nasty stomach bug that causes vomiting and diarrhea. It’s highly contagious and can spread easily in nursing homes and daycares, and on cruise ships. It’s generally a seasonal illness that’s more common in the winter months.”
Never a fun bug to have at all.
With regards to the Phase 3 trials, results are expected later this year, or by early 2026. “Moderna needs to see a certain number of cases before it can analyze the data and determine how well its vaccine works, putting the timeline in flux. The 25,000-person study is enrolling ahead of schedule, said Doran Fink, Moderna’s clinical therapeutic area head for gastrointestinal and bacterial pathogens,” added CNBC.
Again, keep an eye on MRNA. It could see good, near-term upside.
Brownstone Research
Elon’s New Tech Could Be Bigger Than Tesla & SpaceX… Combined
Forget rockets or brain implants…
Elon’s new AI product could be his biggest invention yet.
Jeff Brown tried it himself recently and caught his experience on camera.
Click here to see this footage because according to Tesla Magazine, this new product “could well shape the technological and economic future of our society.”
What stocks do you have your eye on in 2025? Are there any sectors you think will be particularly hot? Hit "reply" to this email and let us know!
Tidak ada komentar:
Posting Komentar